Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

First, let's back up a bit and take a look at the Moderna story, from the glory days of a few years ago to its troubles today ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...

Imagine a world without COVID-19 vaccines: a terrifying reality of endless variants, overwhelmed hospitals, and economies in ...

All of which brings us to May 2020, when the federal government tasked the pharmaceutical industry with producing COVID ...

A new COVID variant - NB 1.8.1 - is creeping across California; here are the symptoms to watch for, and vaccinations you'll ...